摘要 |
It is intended to provide a drug for airway administration containing, as the active ingredient, a compound having a phosphodiesterase (PDE)-IV inhibitory effect which shows a concentration in a lung tissue 350 times or more higher than its concentration in plasma when administered into the airway or a pharmacologically acceptable salt thereof. It is also intended to provide a drug for airway administration in which the compound having the PDE-IV inhibitory effect is, for example, a beznofuran derivative, a 1,3-benzodioxole derivative, etc.
|
申请人 |
KYOWA HAKKO KOGYO CO., LTD.;OHSHIMA, ETSUO;MANABE, HARUHIKO;MIE, MOTOYA;TAHARA, HARUNOBU;YAMAGUCHI, KAZUO;ISHIKAWA, YASUHIRO |
发明人 |
OHSHIMA, ETSUO;MANABE, HARUHIKO;MIE, MOTOYA;TAHARA, HARUNOBU;YAMAGUCHI, KAZUO;ISHIKAWA, YASUHIRO |